HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

β-elemene blocks lipid-induced inflammatory pathways via PPARβ activation in heart failure.

Abstract
This study aims to investigate the effects of β-elemene on a mouse model of heart failure (HF) and to elucidate the underlying mechanisms in vitro approaches. In this study, left anterior descending (LAD)-induced HF mouse model and oxygen-glucose deprivation/recovery (OGD/R)-induced H9C2 model were leveraged to assess the therapeutic effects of β-elemene. Histological examination, western blot and quantitative real-time PCR analysis (RT-qPCR) and immunofluorescence staining was utilized to elucidate mechanism of β-elemene in lipid-induced inflammation. Results showed that β-elemene improved heart function in HF mice evidenced by the increase of cardiac ejection fraction (EF) and fractional shortening (FS) values. Furthermore, β-elemene administration rescued ventricular dilation, lipid accumulation, and inflammatory infiltration in arginal areas of mice myocardial infarction. At transcription level, β-elemene augmented the mRNA expression of fatty acid oxidation-associated genes, such as peroxisome proliferator-activated receptor-β (PPARβ). In vitro, treatment of β-elemene increased carnitine palmitoyltransferase 1A (CPT1A) and sirtuin 3 (SIRT3). Hallmarks of inflammation including the nuclear translocation of nuclear factor κB (NF-κB) and the degradation of inhibitory κBα (IκBα) were significantly suppressed. Consistently, we observed down-regulation of interleukin-6 (IL-6) and pro-inflammatory cytokines (such as TNFα) in β-elemene treated H9C2 cells. Finally, molecular docking model predicted an interaction between β-elemene and PPARβ protein. Furthermore, β-elemene increased the expression of PPARβ, which was validated by antagonist of PPARβ and siRNA for PPARβ.
AuthorsMingyan Shao, Mingmin Wang, Lin Ma, Qian Wang, Pengrong Gao, Xue Tian, Changxiang Li, Linghui Lu, Chun Li, Wei Wang, Yong Wang
JournalEuropean journal of pharmacology (Eur J Pharmacol) Vol. 910 Pg. 174450 (Nov 05 2021) ISSN: 1879-0712 [Electronic] Netherlands
PMID34454927 (Publication Type: Journal Article)
CopyrightCopyright © 2021. Published by Elsevier B.V.
Chemical References
  • Anti-Inflammatory Agents
  • Cardiotonic Agents
  • Ern1 protein, rat
  • Lipids
  • Multienzyme Complexes
  • NF-kappa B
  • PPAR-beta
  • Sesquiterpenes
  • beta-elemene
  • NF-KappaB Inhibitor alpha
  • Protein Serine-Threonine Kinases
  • Endoribonucleases
Topics
  • Animals
  • Anti-Inflammatory Agents (pharmacology, therapeutic use)
  • Cardiotonic Agents (pharmacology, therapeutic use)
  • Cell Line
  • Cell Survival (drug effects)
  • Disease Models, Animal
  • Endoribonucleases (metabolism)
  • Heart Failure (chemically induced, metabolism, pathology, prevention & control)
  • Inflammation (chemically induced, metabolism)
  • Lipids (toxicity)
  • Male
  • Mice
  • Mitochondria (drug effects)
  • Molecular Docking Simulation
  • Multienzyme Complexes (metabolism)
  • NF-KappaB Inhibitor alpha (metabolism)
  • NF-kappa B (metabolism)
  • PPAR-beta (agonists, chemistry, genetics, metabolism)
  • Protein Serine-Threonine Kinases (metabolism)
  • Rats
  • Sesquiterpenes (chemistry, pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: